Heparin for Assisted Reproduction: Summary of a Cochrane Review

Overview

Journal Fertil Steril

Specialty Reproductive Medicine

Date 2014 Oct 6

PMID 25282470

Citations 8

Authors

Muhammad Ahsan Akhtar

Shyamaly Sur

Nick Raine-Fenning

Kannamannadiar Jayaprakasan

Jim Thornton

Siobhan Quenby

Jane Marjoribanks

Affiliations

Soon will be listed here.

Abstract

It is suggested that heparin given in the peri-implantation period may improve clinical outcomes in women undergoing assisted reproduction techniques (ART). This systematic review evaluates the use of heparin in subfertile women undergoing ART.

Citing Articles

Immune Cell Functionality during Decidualization and Potential Clinical Application.

Stope M, Mustea A, Sanger N, Einenkel R Life (Basel). 2023; 13(5).

PMID: 37240742 PMC: 10223169. DOI: 10.3390/life13051097.

Adjuvants in IVF-evidence for what works and what does not work.

Nardo L, Chouliaras S Ups J Med Sci. 2020; 125(2):144-151.

PMID: 32378442 PMC: 7721040. DOI: 10.1080/03009734.2020.1751751.

An enhanced clot growth rate before in vitro fertilization decreases the probability of pregnancy.

Balandina A, Koltsova E, Teterina T, Yakovenko A, Simonenko E, Poletaev A PLoS One. 2019; 14(5):e0216724.

PMID: 31120933 PMC: 6532853. DOI: 10.1371/journal.pone.0216724.

American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy.

Bates S, Rajasekhar A, Middeldorp S, McLintock C, Rodger M, James A Blood Adv. 2018; 2(22):3317-3359.

PMID: 30482767 PMC: 6258928. DOI: 10.1182/bloodadvances.2018024802.

Enhancement of trophoblast differentiation and survival by low molecular weight heparin requires heparin-binding EGF-like growth factor.

Bolnick A, Bolnick J, Kohan-Ghadr H, Kilburn B, Pasalodos O, Singhal P Hum Reprod. 2017; 32(6):1218-1229.

PMID: 28402449 PMC: 6075585. DOI: 10.1093/humrep/dex069.